News
Mr. Philippe Auvaro appointed as Executive Director of MDV,Strengthening overseas medical data business, bringing experience in pharmaceutical business, with a focus on rare diseases and orphan drugs
- January 20, 2022
Medical Data Vision Co., Ltd. (“MDV”) (Chiyoda-ku, Tokyo, President: Hiroyuki Iwasaki), which owns one of the largest medical databases in Japan and promotes data-based medicine, is pleased to announce the appointment of Mr. Philippe Auvaro as its new Executive Director as of January 1, 2022. Mr. Auvaro’s expertise in negotiating with overseas pharmaceutical companies will be fully utilized in the overseas development to promote the data management business. His tasks should also focus on the development of new products and services. Philippe Auvaro is also expected to leverage as well his knowledge in the field of orphan drugs, which is his lifework, not only for business expansion but also to contribute to society.
Comment from Mr. Auvaro
I am very honored to join MDV. It is a challenge for me to contribute to an already successful company. I would like to actively participate in MDV’s growth strategy and explore new areas of activity both domestically and internationally, new applications of data, and collaboration with other companies. My goal is to develop and provide new data to make healthcare more efficient and convenient for all people in Japan.
MDV has been contributing to the development of oncology treatment methods in Japan. I believe that this successful experience will make a significant contribution to the field of orphan drugs, especially in supporting epidemiological studies. I would also like to incorporate my experience in the field of health economics and cost-effectiveness of healthcare into MDV’s operations.
Brief History of the New Executive Director
Philippe Auvaro, born on August 24, 1964 (age 57, French citizen)
Apr 1991Joined Roussel Uclaf S.A.
Sep 1995Joined Nippon Hoechst Marion Roussel Ltd.
Aug 2004Joined Sanofi K.K. formerly known as Sanofi-Aventis K.K.
Apr 2005Joined GlaxoSmithKline K.K. (GSK)
Apr 2012Appointed as Corporate Officer, Head of Business Innovation Group of GSK
Nov 2014Appointed as President and Representative Director of Aspen Japan K.K.
Jul 2016Joined CMIC HOLDINGS Co., Ltd (CMIC) and Appointed as Managing Director, Senior Executive Officer
Appointed as President of OrphanPacific, Inc.
Dec 2016Appointed as Director and Senior Managing Executive Officer of CMIC
Dec 2019Resigned Director and Senior Managing Executive Officer of CMIC
Appointed as Executive Officer of CMIC
Sep 2021Resigned President of OrphanPacific, Inc.
Dec 2021Resigned Senior Executive Officer of CMIC